-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Sunday, Cocrystal Pharma Q3 EPS $(0.20) Misses $(0.18) Estimate, Sales $105.000K

Benzinga·11/16/2026 05:30:14
Listen to the news
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $105.000 thousand in sales this quarter.